Online Exclusives

Online Exclusives

Rethinking Health Care’s Anti-Kickback Laws

The Trump administration issued a request for recommendations on relaxing kickback and self-referral laws that are intended to protect Medicare and Medicaid recipients from...

FDA Approves Frontline Venetoclax for Acute Myeloid Leukemia

The U.S. Food and Drug Administration (FDA) granted accelerated approval to the BCL2 inhibitor venetoclax, in combination with azacitidine or decitabine or low-dose cytarabine,...

Science Faces Its Own Problem With Harassment

To combat an endemic culture of sexual and gender harassment, the National Science Foundation (NSF) and its director France Córdova, PhD, enacted a new...

Report Identifies Gaps in Developing Countries’ Access to Medicines

Access to treatments for underserved populations in developing countries has improved over the years, however, inequities persist – particularly for cancer drugs. In a...

Glasdegib Granted Approval for Older Patients With Acute Myeloid Leukemia

The U.S. Food and Drug Administration (FDA) approved glasdegib in combination with low-dose cytarabine for patients aged 75 years or older with newly diagnosed...

Doctors Refuse to Stay Silent in Face of Latest Mass Shooting

Just hours before a November 7 mass shooting in a bar in Thousand Oaks, CA, the National Rifle Association tweeted that doctors who speak...

Holding Drug Makers and Distributors Accountable for the Opioid Epidemic

Federal government action to stem the opioid crisis has been largely ineffective to date. Some states, tired of shouldering opioid abuse-related hospital bills and...

Pharmacy Benefit Managers for Top U.S. Employers Disallow Drug Coupons

Discount cards issued by drugmakers to patients often keep patients filling pricey prescriptions and prevent them from discontinuing expensive branded drugs or switching to...

Medicine Shortages Loom in Iran as U.S. Reinstates Sanctions

Following the May 2018 decision to pull the U.S. out of the Iran nuclear deal, which was negotiated by the Obama administration and six...

FDA Approves Triplet Regimen for Multiple Myeloma

The U.S. Food and Drug Administration approved elotuzumab in combination with pomalidomide and dexamethasone for the treatment of adult patients with relapsed or refractory...
Advertisement

Current Issue

December 2018, Volume 4, Issue 14

This issue features a look at the consequences of medical errors, an update on the Cancer Moonshot Initiative, a preview of 2018 ASH Annual Meeting, and more.